For informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
Topical thymosin beta-4 studies tested three different wound conditions. Their actual comparisons explain why a broad skin-repair claim goes too far.
Read articleIGF-1 can rise without better sleep. The sermorelin evidence differs from acute GHRH experiments, modified analogues, and direct assessments of sleep quality.
Read articleWhat an IGF-1 LR3 certificate can establish about a sample, and why purity, sterility, biological activity and human safety need different evidence.
Read articleMissing human data cannot establish safety or a precise harm rate. Learn what product characterization, exposure studies and clinical follow-up each add.
Read articleWalk through real MGF papers to distinguish exercise observations, human cell cultures, protein measurements and analytical methods from PEG-MGF treatment evidence.
Read articleTingling is a skin response, not proof of better exercise. Explore the trials that separate beta-alanine absorption, muscle carnosine and performance.
Read articleCitrulline trials measure blood markers, repetitions and muscle changes. Explore why a pump and a lasting training benefit require different evidence.
Read articleNitrate-rich beetroot can change exercise physiology, but faster performance is not universal. Compare trials in club, trained and elite athletes.
Read articleResveratrol did not consistently improve exercise adaptation, and one trial found smaller gains. Understand the trade-offs, favorable signals and study limits.
Read articleWhat spermidine studies reveal about autophagy, blood polyamines, memory and immune cells—and why none is a personal measure of longevity.
Read articleAn ester changes how injectable testosterone is released. Learn why half-life, blood-test timing and symptom relief answer different questions.
Read articleHow tirzepatide's GIP and GLP-1 activity relates to human trial results, and why receptor counts don't rank every clinical benefit.
Read article458–469 of 600 articles
